Harrow Health, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 5 Aug 2026Shareholders voted on company leadership and oversight; all proposals passed shows investor confidence.
Companies share presentations to explain their business to investors and analysts.
Quarterly reports show how much money the company made and spent in early 2026.
Press release and shareholder letter explain financial performance and company developments.
Company borrowed money by selling debt; uses proceeds for growth initiatives and development.
Company set final price and terms for borrowing fifty million dollars from investors.
Company announced plan to borrow fifty million dollars for growth and business opportunities.
Stocky reads Harrow Health, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Harrow Health, Inc.'s most recent tracked filing was a 8-K on 22 Jun 2026: Four directors elected; executive pay and auditor approved.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.